Abstract
Posterior reversible encephalopathy syndrome (PRES) was originally used to describe a reversible, predominantly posterior leukoencephalopathy in patients who had renal insufficiency, hypertension, or who received immunosuppressive therapy. Since PRES is prevalent in children with kidney diseases, awareness and understanding of it is important for practicing pediatric nephrologists. A comprehensive approach to the diagnosis of PRES includes thorough determination of predisposing factors, clinical symptoms, and mandatory appropriate imaging. Unfortunately, the pathophysiology of PRES is still obscure and specificity of radiological examination has not yet been established. Two major predisposing factors, namely hypertension and calcineurin inhibitors, are well recognized. In addition, nephrotic syndrome is a common underlying condition for development of PRES. Frequent symptoms include altered consciousness (coma, stupor, lethargy, confusion), seizure, headache, and visual disturbance. Most of these symptoms usually develop abruptly and resolve within a few weeks after proper management. Cranial magnetic resonance (MR) imaging is the first-line modality of imaging studies for detecting PRES. Diffusion-weighted imaging with quantification of apparent diffusion coefficient (ADC) values by ADC mapping may provide more accurate and specific images in the future.
References
Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500
Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Nishimura G, Hiramoto R, Honda M (2008) Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome. Nephrol Dial Transplant 23:2531–2536
Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Shishido S, Asanuma H, Nishimura G, Hiramoto R, Honda M (2006) Posterior reversible encephalopathy syndrome in children: its high prevalence and more extensive imaging findings. Am J Kidney Dis 48:231–238
Ikeda M, Ito S, Hataya H, Honda M, Anbo K (2001) Reversible posterior leukoencephalopathy in a patient with minimal-change nephrotic syndrome. Am J Kidney Dis 37:E30
Parvex P, Pinsk M, Bell LE, O'Gorman AM, Patenaude YG, Gupta IR (2001) Reversible encephalopathy associated with tacrolimus in pediatric renal transplants. Pediatr Nephrol 16:537–542
Prasad N, Gulati S, Gupta RK, Kumar R, Sharma K, Sharma RK (2003) Is reversible posterior leukoencephalopathy with severe hypertension completely reversible in all patients? Pediatr Nephrol 18:1161–1166
Soylu A, Kavukcu S, Turkmen M, Akbas Y (2001) Posterior leukoencephalopathy syndrome in poststreptococcal acute glomerulonephritis. Pediatr Nephrol 16:601–603
Nakahara C, Hasegawa N, Izumi I, Kanemoto K, Iwasaki N (2005) The use of cyclosporine in a boy with a prior episode of posterior encephalopathy. Pediatr Nephrol 20:657–661
Schwartz RB, Mulkern RV, Gudbjartsson H, Jolesz F (1998) Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol 19:859–862
Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 29:1043–1049
Stott VL, Hurrell MA, Anderson TJ (2005) Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J 35:83–90
Covarrubias DJ, Luetmer PH, Campeau NG (2002) Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 23:1038–1048
Kwon S, Koo J, Lee S (2001) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 24:361–364
Lamy C, Oppenheim C, Meder JF, Mas JL (2004) Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 14:89–96
Crasto SG, Rizzo L, Sardo P, Davini O, De Lucchi R (2004) Reversible encephalopathy syndrome: report of 12 cases with follow-up. Neuroradiology 46:795–804
Kinoshita T, Moritani T, Shrier DA, Hiwatashi A, Wang HZ, Numaguchi Y, Westesson PL (2003) Diffusion-weighted MR imaging of posterior reversible leukoencephalopathy syndrome: a pictorial essay. Clin Imaging 27:307–315
Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 21:1199–1206
Casey SO, Truwit CL (2000) Pontine reversible edema: a newly recognized imaging variant of hypertensive encephalopathy? AJNR Am J Neuroradiol 21:243–245
Schwartz RB (2002) Hyperperfusion encephalopathies: hypertensive encephalopathy and related conditions. Neurologist 8:22–34
Dillon WP, Rowley H (1998) The reversible posterior cerebral edema syndrome. AJNR Am J Neuroradiol 19:591
Pavlakis SG, Frank Y, Chusid R (1999) Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome. J Child Neurol 14:277–281
Vaughan CJ, Delanty N (2000) Hypertensive emergencies. Lancet 356:411–417
Pula JH, Eggenberger E (2008) Posterior reversible encephalopathy syndrome. Curr Opin Ophthalmol 19:479–484
Bartynski WS (2008) Posterior reversible encephalopathy syndrome. I. Fundamental imaging and clinical features. AJNR Am J Neuroradiol 29:1036–1042
Schiff D, Lopes MB (2005) Neuropathological correlates of reversible posterior leukoencephalopathy. Neurocrit Care 2:303–305
Singh N, Bonham A, Fukui M (2000) Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 69:467–472
Gijtenbeek JM, van den Bent MJ, Vecht CJ (1999) Cyclosporine neurotoxicity: a review. J Neurol 246:339–346
Bechstein WO (2000) Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 13:313–326
Ohta T, Sakano T, Shiotsu M, Furue T, Ohtani H, Kinoshita Y, Mizoue T, Kiya K, Tanaka I (2004) Reversible posterior leukoencephalopathy in a patient with Wegener granulomatosis. Pediatr Nephrol 19:442–444
Wright RR, Mathews KD (1996) Hypertensive encephalopathy in childhood. J Child Neurol 11:193–196
Punaro M, Abou-Jaoude P, Cimaz R, Ranchin B (2007) Unusual neurologic manifestations (II): posterior reversible encephalopathy syndrome (PRES) in the context of juvenile systemic lupus erythematosus. Lupus 16:576–579
Won SC, Kwon SY, Han JW, Choi SY, Lyu CJ (2009) Posterior reversible encephalopathy syndrome in childhood with hematologic/oncologic diseases. J Pediatr Hematol Oncol 31:505–508
Lai CC, Chen SJ, Lien SH, Lo CP, Cheng SN (2008) Posterior reversible encephalopathy in a child with Langerhans cell histiocytosis following allogeneic PBSCT treatment with cyclosporine. Eur J Pediatr 167:817–820
Kanekiyo T, Hara J, Matsuda-Hashii Y, Fujisaki H, Tokimasa S, Sawada A, Kubota K, Shimono K, Imai K, Ozono K (2005) Tacrolimus-related encephalopathy following allogeneic stem cell transplantation in children. Int J Hematol 81:264–268
Bohlin AB, Berg U, Englund M, Malm G, Persson A, Tibell A, Tyden G (1990) Central nervous system complications in children treated with ciclosporin after renal transplantation. Child Nephrol Urol 10:225–230
Schwartz RB, Bravo SM, Klufas RA, Hsu L, Barnes PD, Robson CD, Antin JH (1995) Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 165:627–631
Magnasco A, Rossi A, Catarsi P, Gusmano R, Ginevri F, Perfumo F, Ghiggeri GM (2008) Cyclosporin and organ specific toxicity: clinical aspects, pharmacogenetics and perspectives. Curr Clin Pharmacol 3:166–173
Appignani BA, Bhadelia RA, Blacklow SC, Wang AK, Roland SF, Freeman RB Jr (1996) Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. AJR Am J Roentgenol 166:683–688
Doucet A, Favre G, Deschenes G (2007) Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications. Pediatr Nephrol 22:1983–1990
Becquet O, Pasche J, Gatti H, Chenel C, Abely M, Morville P, Pietrement C (2010) Acute post-streptococcal glomerulonephritis in children of French Polynesia: a 3-year retrospective study. Pediatr Nephrol 25:275–280
Gomez-Lado C, Martinon-Torres F, Alvarez-Moreno A, Eiris-Punal J, Carreira-Sande N, Rodriguez-Nunez A, Castro-Gago M (2007) Reversible posterior leukoencephalopathy syndrome: an infrequent complication in the course of haemolytic-uremic syndrome. Rev Neurol 44:475–478
Zhang YX, Liu JR, Ding MP, Huang J, Zhang M, Jansen O, Deuschl G, Eschenfelder CC (2008) Reversible posterior encephalopathy syndrome in systemic lupus erythematosus and lupus nephritis. Intern Med 47:867–875
Ozcakar ZB, Ekim M, Fitoz S, Teber S, Hizel S, Acar B, Yuksel S, Yalcinkaya F (2004) Hypertension induced reversible posterior leukoencephalopathy syndrome: a report of two cases. Eur J Pediatr 163:728–730
De Laat P, Te Winkel ML, Devos AS, Catsman-Berrevoets CE, Pieters R, van den Heuvel-Eibrink MM (2011) Posterior reversible encephalopathy syndrome in childhood cancer. Ann Oncol 22:472–478
Sanchez-Carteyron A, Alarcia R, Ara JR, Martin J (2010) Posterior reversible encephalopathy syndrome after rituximab infusion in neuromyelitis optica. Neurology 74:1471–1473
Ong B, Bergin P, Heffernan T, Stuckey S (2009) Transient seizure-related MRI abnormalities. J Neuroimaging 19:301–310
Doelken M, Lanz S, Rennert J, Alibek S, Richter G, Doerfler A (2007) Differentiation of cytotoxic and vasogenic edema in a patient with reversible posterior leukoencephalopathy syndrome using diffusion-weighted MRI. Diagn Interv Radiol 13:125–128
Benziada-Boudour A, Schmitt E, Kremer S, Foscolo S, Riviere AS, Tisserand M, Boudour A, Bracard S (2009) Posterior reversible encephalopathy syndrome: a case of unusual diffusion-weighted MR images. J Neuroradiol 36:102–105
Ishikura K, Hamasaki Y, Sakai T, Hataya H, Goto T, Miyama S, Kono T, Honda M (2010) Children with posterior reversible encephalopathy syndrome associated with atypical diffusion-weighted imaging and apparent diffusion coefficient. Clin Exp Nephrol. doi:10.1007/s10157-010-0380-2
Servillo G, Bifulco F, De Robertis E, Piazza O, Striano P, Tortora F, Striano S, Tufano R (2007) Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med 33:230–236
Bartynski WS, Boardman JF (2008) Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 29:447–455
Bartynski WS, Boardman JF (2007) Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 28:1320–1327
Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA (2010) Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 85:427–432
Epker JL, van Biezen P, van Daele PL, van Gelder T, Vossen A, van Saase JL (2009) Progressive multifocal leukoencephalopathy, a review and an extended report of five patients with different immune compromised states. Eur J Intern Med 20:261–267
Paues J, Vrethem M (2010) Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab. J Clin Virol 48:291–293
Kumar D (2010) Emerging viruses in transplantation. Curr Opin Infect Dis 23:374–378
Yoon JH, Bang OY, Kim HS (2007) Progressive multifocal leukoencephalopathy in AIDS: proton MR spectroscopy patterns of asynchronous lesions confirmed by serial diffusion-weighted imaging and apparent diffusion coefficient mapping. J Clin Neurol 3:200–203
Ko MW, Liu GT (2010) Pediatric idiopathic intracranial hypertension (pseudotumor cerebri). Horm Res Paediatr 74:381–389
Acknowledgements
The authors would like to thank Dr. Shuichi Ito, Dr. Tatsuo Kono, Dr. Tomohide Goto, and Dr. Sahoko Miyama who provided generous advice in preparing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Answers
1. e
2. b
3. b
4. e
5. c
Rights and permissions
About this article
Cite this article
Ishikura, K., Hamasaki, Y., Sakai, T. et al. Posterior reversible encephalopathy syndrome in children with kidney diseases. Pediatr Nephrol 27, 375–384 (2012). https://doi.org/10.1007/s00467-011-1873-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-011-1873-2